Results 1 to 10 of about 204,293 (233)

Emergence of highly resistant Candida auris in the United Arab Emirates: a retrospective analysis of evolving national trends [PDF]

Frontiers in Public Health
IntroductionThe Centers for Disease Prevention and Control lists Candida auris, given its global emergence, multidrug resistance, high mortality, and persistent transmissions in health care settings as one of five urgent threats.
Jens Thomsen, Jens Thomsen, Najiba M. Abdulrazzaq, Abderrahim Oulhaj, Peter S. Nyasulu, Adnan Alatoom, David W. Denning, Fatima Al Dhaheri, the UAE AMR Surveillance Consortium, Godfred Antony Menezes, Carole Ayoub Moubareck, Abiola Senok, Abiola Senok, Dean B. Everett, Dean B. Everett, Dean B. Everett   +15 more
doaj   +4 more sources

Candida auris Genetics and Emergence

Annual Review of Microbiology, 2023
Candida auris is a multidrug-resistant fungal pathogen that presents a serious threat to global human health. Since the first reported case in 2009 in Japan, C. auris infections have been reported in more than 40 countries, with mortality rates between 30% and 60%. In addition, C.
Anuradha Chowdhary, Kusum Jain, Neeraj Chauhan   +2 more
openaire   +3 more sources

Thermogenic Characterization and Antifungal Susceptibility of Candida auris by Microcalorimetry [PDF]

Journal of Fungi, 2019
Candida auris has emerged globally as a multidrug-resistant fungal pathogen. Isolates of C. auris are reported to be misidentified as Candida haemulonii. The aim of the study was to compare the heat production profiles of C.
Mariagrazia Di Luca, Anna Koliszak, Svetlana Karbysheva, Anuradha Chowdhary, Jacques F. Meis, Andrej Trampuz   +5 more
doaj   +3 more sources

Candida auris

Nursing
Abstract: Candida auris (C. auris) is a human pathogen that can colonize the skin and various body sites without signs or symptoms or cause serious invasive infections with high mortality. The number of cases involving drug-resistant C. auris infections have increased in the US in recent years.
Jenks J, Tobin EH, Zahra F.
europepmc   +5 more sources

Candida auris: A Continuing Threat

Microorganisms
Candida auris is a World Health Organization critical-priority fungal pathogen that has variable resistance to antifungal treatments. Multiple clades have been identified through genomic analysis and have appeared in different geographic locations simultaneously.
Ashish Bhargava, Katherine Klamer, Mamta Sharma, Daniel Ortiz, Louis Saravolatz   +4 more
openaire   +4 more sources

Analysis of Candida auris resistance and associated risk factors in hospitalized patients at a tertiary care hospital in China [PDF]

Scientific Reports
Candida auris (Candidozyma auris, C. auris) is a significant concern in infection prevention. This study aims to analyze the antifungal susceptibility of C. auris isolates and risk factors of C.
Ting Fan, Zihuan Li, Zhenyao Zhao, Baohong Liu, Cuiqiong Fan, Tian Wang, Miao Yang, Yundao Li, Maorui Lin, Guanwen Lin   +9 more
doaj   +2 more sources

Candida auris: Epidemiology and Antifungal Strategy

Annual Review of Medicine
Candida auris is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes C. auris from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare facilities via patient-to-patient transmission. C.
Eix, Emily F., Nett, Jeniel E.
openaire   +3 more sources

Skin and hard surface disinfection against Candida auris – What we know today

Frontiers in Medicine
Candida auris has emerged as a global healthcare threat, displaying resistance to important healthcare antifungal therapies. Infection prevention and control protocols have become paramount in reducing transmission of C.
Soraya Omardien, Peter Teska
doaj   +2 more sources

Activity of rezafungin against Candida auris. [PDF]

J Antimicrob Chemother
Abstract The increasing prevalence of candidemia and invasive candidiasis infections caused by Candida auris represents a global health risk. Such infections are difficult to treat as they are often multidrug-resistant and are linked to high rates of mortality.
Locke JB, Andes D, Flanagan S, Redell M, Ong V, Aram JA, Pappas PG, Castanheira M, Thompson GR.   +8 more
europepmc   +3 more sources

Analysis of Candida auris fungemia at a single facility in Kenya [PDF]

International Journal of Infectious Diseases, 2019
Objectives: Candida auris emerged as a human pathogen in 2009 and has subsequently been identified around the world as a cause of invasive candidiasis.
Rodney D. Adam, Gunturu Revathi, Nancy Okinda, Melanie Fontaine, Jasmit Shah, Elizabeth Kagotho, Mariana Castanheira, Michael A. Pfaller, Daniel Maina   +8 more
doaj   +3 more sources